دورية أكاديمية

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
المؤلفون: Gallant, Joel E, Daar, Eric S, Raffi, François, Brinson, Cynthia, Ruane, Peter, DeJesus, Edwin, Johnson, Margaret, Clumeck, Nathan, Osiyemi, Olayemi, Ward, Doug, Morales-Ramirez, Javier, Yan, Mingjin, Abram, Michael E, Plummer, Andrew, Cheng, Andrew K, Rhee, Martin S
المصدر: In The Lancet HIV April 2016 3(4):e158-e165
قاعدة البيانات: ScienceDirect
الوصف
تدمد:23523018
DOI:10.1016/S2352-3018(16)00024-2